ResearcherRuijin HospitalActive in the last 2 years

M.D.&Ph.D Baiyong Shen

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 6 November 2026

Known by name at one institution; no external author ID yet. Sources: ClinicalTrials.gov.

Their work

Papers: 0
Trials: 3
Grants: 0
Labs led: 0
Collaborators: 0

Papers, trials and grants by year

2022: 1 trial · 2023: 1 trial · 2024: 1 trial

Trials 3

Clinical Study of mRNA Vaccine Combined With PD-1 Inhibitor as Adjuvant Therapy for Postoperative Pancreatic Cancer Study director NCT06496373 ↗
Personalized Tumor Vaccines and Pabolizumab in Patients With Advanced Pancreatic Cancer Study director NCT05916261 ↗
AssesSment of Early-deteCtion basEd oN liquiD Biopsy in PANCEATIC Cancer (ASCEND-PANCREATIC) Study director NCT05556603 ↗

Closest collaborators

No collaborators recorded.

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.